Primary intracerebral melanoma: A case report

Primary intracranial malignant melanoma is an extremely rare entity These aggressive tumors are derived from the melanocytes of leptomeninges or their precursor cells and can give metastasis to other organs. It effects mostly middle aged males and represents a very poor prognosis with median surviva...

Full description

Bibliographic Details
Main Authors: Paunović Aleksandra, Lazić Igor, Milisavljević Filip, Miljković Aleksandar, Nedeljković Žarko, Bogdanović Ivan, Rakonjac Marija, Ilić Rosanda
Format: Article
Language:English
Published: Specijalna bolnica za bolesti štitaste žlezde i bolesti metabolizma Zlatibor 2021-01-01
Series:Medicinski Glasnik Specijalne Bolnice za Bolesti Štitaste Žlezde i Bolesti Metabolizma "Zlatibor"
Online Access:https://scindeks-clanci.ceon.rs/data/pdf/1821-1925/2021/1821-19252183053P.pdf
_version_ 1811335474610962432
author Paunović Aleksandra
Lazić Igor
Milisavljević Filip
Miljković Aleksandar
Nedeljković Žarko
Bogdanović Ivan
Rakonjac Marija
Ilić Rosanda
author_facet Paunović Aleksandra
Lazić Igor
Milisavljević Filip
Miljković Aleksandar
Nedeljković Žarko
Bogdanović Ivan
Rakonjac Marija
Ilić Rosanda
author_sort Paunović Aleksandra
collection DOAJ
description Primary intracranial malignant melanoma is an extremely rare entity These aggressive tumors are derived from the melanocytes of leptomeninges or their precursor cells and can give metastasis to other organs. It effects mostly middle aged males and represents a very poor prognosis with median survival less than 1 year. For proper diagnosis, melanoma of other localization must be excluded. Giving the rarity of this tumor, treatment of choice in unclear. We report a case of 43 year old patient with primary intracranial melanoma treated by supramarginal resection followed by whole brain RT, with disease free period of three years following treatment. We strongly advocate for aggressive treatment approach, supramarginal resection whenever safe, adjuvant therapy and frequent check-ups. We also hope to inspire future studies on larger sample to in order to establish an adequate therapy protocols.
first_indexed 2024-04-13T17:24:43Z
format Article
id doaj.art-0ceac77faec94098aeea40790a3c9d3d
institution Directory Open Access Journal
issn 1821-1925
2406-131X
language English
last_indexed 2024-04-13T17:24:43Z
publishDate 2021-01-01
publisher Specijalna bolnica za bolesti štitaste žlezde i bolesti metabolizma Zlatibor
record_format Article
series Medicinski Glasnik Specijalne Bolnice za Bolesti Štitaste Žlezde i Bolesti Metabolizma "Zlatibor"
spelling doaj.art-0ceac77faec94098aeea40790a3c9d3d2022-12-22T02:37:49ZengSpecijalna bolnica za bolesti štitaste žlezde i bolesti metabolizma ZlatiborMedicinski Glasnik Specijalne Bolnice za Bolesti Štitaste Žlezde i Bolesti Metabolizma "Zlatibor"1821-19252406-131X2021-01-012683537010.5937/mgiszm2183053P1821-19252183053PPrimary intracerebral melanoma: A case reportPaunović Aleksandra0Lazić Igor1Milisavljević Filip2Miljković Aleksandar3Nedeljković Žarko4Bogdanović Ivan5Rakonjac Marija6Ilić Rosanda7Univerzitetski Klinički centar Srbije, Neurohirurška klinika, Beograd, SerbiaUniverzitetski Klinički centar Srbije, Centar za anesteziologiju, Beograd, SerbiaUniverzitetski Klinički centar Srbije, Neurohirurška klinika, Beograd, SerbiaUniverzitetski Klinički centar Srbije, Neurohirurška klinika, Beograd, SerbiaUniverzitetski Klinički centar Srbije, Neurohirurška klinika, Beograd, SerbiaUniverzitetski Klinički centar Srbije, Neurohirurška klinika, Beograd, SerbiaUniverzitetski Klinički centar Srbije, Centar za anesteziologiju, Beograd, SerbiaUniverzitetski Klinički centar Srbije, Neurohirurška klinika, Beograd, SerbiaPrimary intracranial malignant melanoma is an extremely rare entity These aggressive tumors are derived from the melanocytes of leptomeninges or their precursor cells and can give metastasis to other organs. It effects mostly middle aged males and represents a very poor prognosis with median survival less than 1 year. For proper diagnosis, melanoma of other localization must be excluded. Giving the rarity of this tumor, treatment of choice in unclear. We report a case of 43 year old patient with primary intracranial melanoma treated by supramarginal resection followed by whole brain RT, with disease free period of three years following treatment. We strongly advocate for aggressive treatment approach, supramarginal resection whenever safe, adjuvant therapy and frequent check-ups. We also hope to inspire future studies on larger sample to in order to establish an adequate therapy protocols.https://scindeks-clanci.ceon.rs/data/pdf/1821-1925/2021/1821-19252183053P.pdf
spellingShingle Paunović Aleksandra
Lazić Igor
Milisavljević Filip
Miljković Aleksandar
Nedeljković Žarko
Bogdanović Ivan
Rakonjac Marija
Ilić Rosanda
Primary intracerebral melanoma: A case report
Medicinski Glasnik Specijalne Bolnice za Bolesti Štitaste Žlezde i Bolesti Metabolizma "Zlatibor"
title Primary intracerebral melanoma: A case report
title_full Primary intracerebral melanoma: A case report
title_fullStr Primary intracerebral melanoma: A case report
title_full_unstemmed Primary intracerebral melanoma: A case report
title_short Primary intracerebral melanoma: A case report
title_sort primary intracerebral melanoma a case report
url https://scindeks-clanci.ceon.rs/data/pdf/1821-1925/2021/1821-19252183053P.pdf
work_keys_str_mv AT paunovicaleksandra primaryintracerebralmelanomaacasereport
AT lazicigor primaryintracerebralmelanomaacasereport
AT milisavljevicfilip primaryintracerebralmelanomaacasereport
AT miljkovicaleksandar primaryintracerebralmelanomaacasereport
AT nedeljkoviczarko primaryintracerebralmelanomaacasereport
AT bogdanovicivan primaryintracerebralmelanomaacasereport
AT rakonjacmarija primaryintracerebralmelanomaacasereport
AT ilicrosanda primaryintracerebralmelanomaacasereport